Literature DB >> 101028

Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease.

A A Moss, J V Carbone, H Y Kressel.   

Abstract

Continuous treatment with broad-spectrum antibiotics resulted in symptomatic improvement in 41 of 44 patients (93%) with Crohn's disease who were treated for 6 months or longer. Radiographic follow-up demonstrated evidence of improvement in 20 of 35 patients (57%) for whom posttherapy radiographs were available. Radiography demonstrated resolution of ulcerations, abdominal masses, stenosis, and in some patients restoration of a normal intestinal mucosal pattern. In some patients these changes occurred within weeks; in others, over a period of years. Patients with perianal fistulas and patients who had previously undergone surgery and had recurrence of their disease prior to treatment with antibiotics accounted for the therapy failures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101028     DOI: 10.2214/ajr.131.5.787

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Inflammatory bowel disease in the elderly. Practical treatment guidelines.

Authors:  G A Akerkar; M A Peppercorn
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

Review 2.  Bacterial persistence and expression of disease.

Authors:  G J Domingue; H B Woody
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 3.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

4.  Crohn's disease: drug therapy, diet or surgery?

Authors:  R Elliott
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

Review 5.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

6.  Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease.

Authors:  B I Korelitz; D H Present
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.